These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17455969)
1. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues. Zou Y; Wang Y J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969 [TBL] [Abstract][Full Text] [Related]
2. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein. Zou Y; Wang Y Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918 [TBL] [Abstract][Full Text] [Related]
3. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Edberg DD; Bruce JE; Siems WF; Reeves R Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136 [TBL] [Abstract][Full Text] [Related]
4. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. Edberg DD; Adkins JN; Springer DL; Reeves R J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590 [TBL] [Abstract][Full Text] [Related]
5. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation. Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233 [TBL] [Abstract][Full Text] [Related]
6. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells. Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028 [TBL] [Abstract][Full Text] [Related]
7. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells. Jiang X; Wang Y Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910 [TBL] [Abstract][Full Text] [Related]
8. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin. Sharma A; Ray R; Rajeswari MR Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743 [TBL] [Abstract][Full Text] [Related]
9. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line. Akhter MZ; Sharma A; Rajeswari MR Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378 [TBL] [Abstract][Full Text] [Related]
10. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties. Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492 [TBL] [Abstract][Full Text] [Related]
12. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. Zhang Q; Zhang K; Zou Y; Perna A; Wang Y J Am Soc Mass Spectrom; 2007 Sep; 18(9):1569-78. PubMed ID: 17627840 [TBL] [Abstract][Full Text] [Related]
13. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells. Cuomo A; Moretti S; Minucci S; Bonaldi T Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350 [TBL] [Abstract][Full Text] [Related]
14. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722 [TBL] [Abstract][Full Text] [Related]
15. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. Zhang Q; Wang Y J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875 [TBL] [Abstract][Full Text] [Related]
16. High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Treff NR; Pouchnik D; Dement GA; Britt RL; Reeves R Oncogene; 2004 Jan; 23(3):777-85. PubMed ID: 14737112 [TBL] [Abstract][Full Text] [Related]
17. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry. Sgarra R; Diana F; Bellarosa C; Dekleva V; Rustighi A; Toller M; Manfioletti G; Giancotti V Biochemistry; 2003 Apr; 42(12):3575-85. PubMed ID: 12653562 [TBL] [Abstract][Full Text] [Related]
18. Differential HMGA expression and post-translational modifications in prostatic tumor cells. Diana F; Di Bernardo J; Sgarra R; Tessari MA; Rustighi A; Fusco A; Giancotti V; Manfioletti G Int J Oncol; 2005 Feb; 26(2):515-20. PubMed ID: 15645138 [TBL] [Abstract][Full Text] [Related]
19. Mapping of lysine monomethylation of linker histones in human breast and its cancer. Lu A; Zougman A; Pudełko M; Bebenek M; Ziółkowski P; Mann M; Wiśniewski JR J Proteome Res; 2009 Sep; 8(9):4207-15. PubMed ID: 19552482 [TBL] [Abstract][Full Text] [Related]
20. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase. Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]